Journal of Thrombosis and Haemostasis, 1538-7933

Journal

More filtering options
  1. Article
  2. Genome-wide analysis of genetic determinants of circulating factor VII-activating protease (FSAP) activity

    Olsson, M., Stanne, T. M., Pedersen, A., Lorentzen, E., Kara, E., Martinez-Palacian, A., Rønnow Sand, N. P., Jacobsen, A. F., Sandset, P. M., Sidelmann, J. J., G. Engström, O. Melander, Kanse, S. M. & Jern, C., 2018, In : Journal of Thrombosis and Haemostasis. 16, 10, p. 2024-2034

    Research output: Contribution to journalArticle

  3. Effect of late prophylaxis in hemophilia on joint status: A randomized trial

    Manco-Johnson, M. J., B. Lundin, Funk, S., Peterfy, C., Raunig, D., Werk, M., Kempton, C. L., Reding, M. T., Goranov, S., Gercheva, L., Rusen, L., Uscatescu, M. V., Pierdominici, M., Engelen, S., Pocoski, J., Walker, D. & Hong, W., 2017 Nov, In : Journal of Thrombosis and Haemostasis. 15, 11, p. 2115-2124

    Research output: Contribution to journalArticle

  4. Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients: Results of the INSIGHT case-control study

    van Velzen, A. S., Eckhardt, C. L., Peters, M., Leebeek, F. W. G., Escuriola-Ettingshausen, C., Hermans, C., Keenan, R. D., J. Astermark, Male, C., Peerlinck, K., le Cessie, S., Van der Bom, J. G. & Fijnvandraat, K., 2017 Jul 3, In : Journal of Thrombosis and Haemostasis. 15, 7, p. 1422-1429

    Research output: Contribution to journalArticle

  5. Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia - a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study.

    Tuckuviene, R., Ranta, S., Albertsen, B. K., Andersson, N. G., Bendtsen, M. D., Frisk, T., Gunnes, M. W., Helgestad, J., Heyman, M. M., Jonsson, O. G., Mäkipernaa, A., Pruunsild, K., Ulf Tedgård, Trakymiene, S. S. & Ruud, E., 2016, In : Journal of Thrombosis and Haemostasis. 14, 3, p. 485-494

    Research output: Contribution to journalArticle

  6. Population Pharmacokinetics of Plasma-Derived Factor IX: Procedures for Dose Individualization.

    Brekkan, A., Erik Berntorp, Jensen, K., Nielsen, E. I. & Jönsson, S., 2016, In : Journal of Thrombosis and Haemostasis. 14, 4, p. 724-732

    Research output: Contribution to journalArticle

  7. The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation.

    Kozarcanin, H., Lood, C., Munthe-Fog, L., Sandholm, K., Hamad, O. A., Anders Bengtsson, Skjoedt, M-O., Huber-Lang, M., Garred, P., Ekdahl, K. N. & Nilsson, B., 2016, In : Journal of Thrombosis and Haemostasis. 14, 3, p. 531-545

    Research output: Contribution to journalArticle

  8. Measuring factor IX activity of nonacog beta pegol with commercially available one-stage clotting and chromogenic assay kits: A two-center study

    Bowyer, A. E., A. Hillarp, Ezban, M., Persson, P. & Kitchen, S., 2016, In : Journal of Thrombosis and Haemostasis. 14, 7, p. 1428-1435

    Research output: Contribution to journalArticle

  9. Prophylaxis Escalation in Severe von Willebrand Disease: A Prospective Study from the von Willebrand Disease Prophylaxis Network.

    Abshire, T., Cox-Gill, J., Kempton, C. L., Leebeek, F. W. G., Carcao, M., Kouides, P., Donfield, S. & Erik Berntorp, 2015, In : Journal of Thrombosis and Haemostasis. 13, 9, p. 1585-1589

    Research output: Contribution to journalArticle

  10. Effects of recombinant human prothrombin on thrombin generation in plasma from patients with haemophilia A and B.

    Hansson, K. M., Gustafsson, D., Skärby, T., Frison, L. & Erik Berntorp, 2015, In : Journal of Thrombosis and Haemostasis. 13, 7, p. 1293-1300

    Research output: Contribution to journalArticle

  11. The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A

    Eckhardt, C. L., Jan Astermark, Nagelkerke, S. Q., Geissler, J., Tanck, M. W. T., Peters, M., Fijnvandraat, K. & Kuijpers, T. W., 2014, In : Journal of Thrombosis and Haemostasis. 12, 8, p. 1294-1301

    Research output: Contribution to journalArticle

  12. Elevated risk of venous but not arterial thrombosis in Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma

    Hultcrantz, M., Pfeiffer, R. M., Bjorkholm, M., Goldin, L. R., Ingemar Turesson, Schulman, S., Landgren, O. & Kristinsson, S. Y., 2014, In : Journal of Thrombosis and Haemostasis. 12, 11, p. 1816-1821

    Research output: Contribution to journalArticle

  13. Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-Xa assays.

    Andreas Hillarp, Gustafsson, K. M., Faxälv, L., Strandberg, K., Baghaei, F., Fagerberg Blixter, I., Berndtsson, M. & Lindahl, T. L., 2014, In : Journal of Thrombosis and Haemostasis. 12, 9, p. 1545-1553

    Research output: Contribution to journalArticle

  14. Definitions in hemophilia: communication from the SSC of the ISTH

    Blanchette, V. S., Key, N. S., Rolf Ljung, Manco-Johnson, M. J., Van Den Berg, H. M. & Srivastava, A., 2014, In : Journal of Thrombosis and Haemostasis. 12, 11, p. 1935-1939

    Research output: Contribution to journalArticle

  15. 40K glycoPEGylated, recombinant FVIIa: 3-month, double-blind, randomized trial of safety, pharmacokinetics, and preliminary efficacy in hemophilia patients with inhibitors.

    Rolf Ljung, Karim, F. A., Saxena, K., Suzuki, T., Arkhammar, P., Rosholm, A. & Giangrande, P., 2013, In : Journal of Thrombosis and Haemostasis. 11, 7, p. 1260-1268

    Research output: Contribution to journalArticle

  16. Origin of Swedish hemophilia B mutations

    Hallden, C., Annika Mårtensson, Nilsson, D., Torbjörn Säll, Lind-Hallden, C., Liden, A. C. & Rolf Ljung, 2013, In : Journal of Thrombosis and Haemostasis. 11, 11, p. 2001-2008

    Research output: Contribution to journalArticle

  17. Origin of Swedish hemophilia A mutations

    Halldén, C., Nilsson, D., Torbjörn Säll, Lind-Hallden, C., Liden, A. C. & Rolf Ljung, 2012, In : Journal of Thrombosis and Haemostasis. 10, 12, p. 2503-2511

    Research output: Contribution to journalArticle

  18. Demographic and clinical data in acquired hemophilia a: results from the european acquired haemophilia (each2) registry.

    Knoebl, P., Paese, M., Baudo, F., Collins, P., Huth-Kühne, A., Nemes, L., Pellegrini, F., Lilian Tengborn & Lévesque, H., 2012, In : Journal of Thrombosis and Haemostasis. 10, 4, p. 622-631

    Research output: Contribution to journalArticle

  19. Mortality and Inherited Thrombophilia: results from the European Prospective Cohort on Thrombophilia (EPCOT).

    Pabinger, I., Vossen, C. Y., Lang, J., Conard, J., García-Dabrio, M. C., Miesbach, W., Legnani, C., Peter Svensson, Kaider, A. & Rosendaal, F. R., 2012, In : Journal of Thrombosis and Haemostasis. 10, 2, p. 217-222

    Research output: Contribution to journalArticle

  20. Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9-GP), a glycoPEGylated recombinant factor IX.

    Collins, P. W., Møss, J., Knobe, K., Groth, A., Colberg, T. & Watson, E., 2012, In : Journal of Thrombosis and Haemostasis. 10, 11, p. 2305-2312

    Research output: Contribution to journalArticle

  21. Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIa.

    Clark, C. A., Vatsyayan, R., Hedner, U., Esmon, C. T., Pendurthi, U. R. & Rao, L. V. M., 2012, In : Journal of Thrombosis and Haemostasis. 10, 11, p. 2383-2391

    Research output: Contribution to journalArticle

  22. Induction of Auto-Antibodies Against β(2) -Glycoprotein I in Mice by Protein H of Streptococcus Pyogenes.

    van Os, G. M. A., Meijers, J. C. M., Ağar, C., Valls Serón, M., Marquart, J. A., Per Åkesson, Urbanus, R. T., Derksen, R. H. W. M., Heiko Herwald, Mörgelin, M. & de Groot, P. G., 2011, In : Journal of Thrombosis and Haemostasis. 9, 12, p. 2447-2456

    Research output: Contribution to journalArticle

  23. Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following IV administration in haemophilia patients.

    Agersø, H., Brophy, D. F., Pelzer, H., Martin, E. J., Carr, M., Hedner, U. & Ezban, M., 2011, In : Journal of Thrombosis and Haemostasis. 9, 2, p. 333-338

    Research output: Contribution to journalArticle

  24. Succinate independently stimulates full platelet activation via cAMP and PI3β kinase signaling.

    Högberg, C., Olof Gidlöf, Tan, C., Svensson, S., Öhman, J., David Erlinge & Björn Olde, 2011, In : Journal of Thrombosis and Haemostasis. 9, 2, p. 361-372

    Research output: Contribution to journalArticle

  25. A Randomized Clinical Trial of Prophylaxis in Children with Hemophilia A (the ESPRIT Study).

    Gringeri, A., Björn Lundin, Mackensen, S. V., Mantovani, L. & Mannucci, P. M., 2011, In : Journal of Thrombosis and Haemostasis. 9, p. 700-710

    Research output: Contribution to journalArticle

  26. Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays.

    Andreas Hillarp, Baghaei, F., Blixter, I. F., Gustafsson, K. M., Stigendal, L., Sten-Linder, M., Strandberg, K. & Lindahl, T. L., 2011, In : Journal of Thrombosis and Haemostasis. 9, p. 133-139

    Research output: Contribution to journalArticle

  27. Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa).

    Tiede, A., Friedrich, U., Stenmo, C., Allen, G., Giangrande, P., Goudemand, J., Hay, C., Holmström, E. M., Klamroth, R., Lethagen, S., McKenzie, S., Miesbach, W., Negrier, C., Yuste, V. J. & Erik Berntorp, 2011, In : Journal of Thrombosis and Haemostasis. 9, p. 1191-1199

    Research output: Contribution to journalArticle

  28. Bio-distribution of pharmacologically administered recombinant factor VIIa (rFVIIa)

    Gopalakrishnan, R., Hedner, U., Ghosh, S., Nayak, R. C., Allen, T. C., Pendurthi, U. R. & Rao, L. V. M., 2010, In : Journal of Thrombosis and Haemostasis. 8, 2, p. 301-310

    Research output: Contribution to journalArticle

  29. Gas6 is complexed to soluble tyrosine kinase receptor Axl in human blood.

    Carl Ekman, Stenhoff, J. & Björn Dahlbäck, 2010, In : Journal of Thrombosis and Haemostasis. 8, 4, p. 838-844

    Research output: Contribution to journalArticle

  30. Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay using a novel automated assay protocol.

    Andreas Hillarp, Stadler, M., Haderer, C., Weinberger, J., Kessler, C. M. & Römisch, J., 2010, In : Journal of Thrombosis and Haemostasis. 8, p. 2216-2223

    Research output: Contribution to journalArticle

  31. The role of phospholipid transfer protein in lipoprotein-mediated neutralization of the procoagulant effect of anionic liposomes.

    Oslakovic, C., Jauhiainen, M., Ehnholm, C. & Björn Dahlbäck, 2010, In : Journal of Thrombosis and Haemostasis. 8, p. 766-772

    Research output: Contribution to journalArticle

  32. Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

    Collins, P. W., Blanchette, V. S., Fischer, K., Bjorkman, S., Oh, M., Fritsch, S., Schroth, P., Spotts, G., Jan Astermark & Ewenstein, B., 2009, In : Journal of Thrombosis and Haemostasis. 7, 3, p. 413-420

    Research output: Contribution to journalArticle

  33. The activation peptide of thrombin-activatable fibrinolysis inhibitor: a role in activity and stability of the enzyme?

    Marx, P. F., Plug, T., Havik, S. R., Mörgelin, M. & Meijers, J. C. M., 2009, In : Journal of Thrombosis and Haemostasis. 7, 3, p. 445-452

    Research output: Contribution to journalArticle

  34. Does an active sun exposure habit lower the risk of venous thrombotic events? A D-lightful hypothesis

    Lindqvist, P. G., Epstein, E. & Håkan Olsson, 2009, In : Journal of Thrombosis and Haemostasis. 7, 4, p. 605-610

    Research output: Contribution to journalArticle

  35. Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A

    Pavlova, A., Delev, D., Lacroix-Desmazes, S., Schwaab, R., Mende, M., Fimmers, R., Jan Astermark & Oldenburg, J., 2009, In : Journal of Thrombosis and Haemostasis. 7, 12, p. 2006-2015

    Research output: Contribution to journalArticle

  36. Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)

    Budde, U., Schneppenheim, R., Eikenboom, J., Goodeve, A., Will, K., Drewke, E., Castaman, G., Rodeghiero, F., Federici, A. B., Batlle, J., Perez, A., Meyer, D., Mazurier, C., Goudemand, J., Ingerslev, J., Habart, D., Vorlova, Z., Holmberg, L., Lethagen, S., Pasi, J. & 2 othersHill, F. & Peake, I., 2008, In : Journal of Thrombosis and Haemostasis. 6, 5, p. 762-771

    Research output: Contribution to journalArticle

  37. Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats

    Lauritzen, B., Hedner, U., Johansen, P. B., Tranholm, M. & Ezban, M., 2008, In : Journal of Thrombosis and Haemostasis. 6, 5, p. 804-811

    Research output: Contribution to journalArticle

  38. Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)

    Tosetto, A., Rodeghiero, F., Castaman, G., Bernardi, M., Bertoncello, K., Goodeve, A., Federici, A. B., Batlle, J., Meyer, D., Mazurier, C., Goudemand, J., Eikenboom, J., Schneppenheim, R., Budde, U., Ingerslev, J., Vorlova, Z., Habart, D., Holmberg, L., Lethagen, S., Pasi, J. & 2 othersHill, F. & Peake, I., 2007, In : Journal of Thrombosis and Haemostasis. 5, 4, p. 715-721

    Research output: Contribution to journalArticle

  39. Von Willebrand factor/factor VIII concentrate (Haemate(R) P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery.

    Lethagen, S., Kyrle, P. A., Castaman, G., Haertel, S. & Mannucci, P. M., 2007, In : Journal of Thrombosis and Haemostasis. 5, Apr 16, p. 1420-1430

    Research output: Contribution to journalArticle

  40. Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin (R)): a prospective study of 50 patients

    Borel-Derlon, A., Federici, A. B., Roussel-Robert, V., Goudemand, J., Lee, C. A., Scharrer, I., Rothschild, C., Erik Berntorp, Henriet, C., Tellier, Z., Bridey, F. & Mannucci, P. M., 2007, In : Journal of Thrombosis and Haemostasis. 5, 6, p. 1115-1124

    Research output: Contribution to journalArticle

  41. Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A

    Jan Astermark, Wang, X., Oldenburg, J., Erik Berntorp & Lefvert, A. -K., 2007, In : Journal of Thrombosis and Haemostasis. 5, 2, p. 263-265

    Research output: Contribution to journalArticle

  42. Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice

    Annika Jögi, Pass, J., Hoyer-Hansen, G., Lund, L. R., Nielsen, B. S., Dano, K. & Romer, J., 2007, In : Journal of Thrombosis and Haemostasis. 5, 9, p. 1936-1944

    Research output: Contribution to journalArticle

  43. Potential role of rFVIIa in prophylaxis in severe haemophilia patients with inhibitors.

    Hedner, U., 2006, In : Journal of Thrombosis and Haemostasis. 4, Aug 14, p. 2498-2500

    Research output: Contribution to journalArticle

Previous 1 2 3 Next